Technical analysis of Applied Therapeutics Inc (APLT) stock chart patterns

While Applied Therapeutics Inc has overperformed by 0.88%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, APLT fell by -61.67%, with highs and lows ranging from $10.62 to $1.12, whereas the simple moving average fell by -80.77% in the last 200 days.

On December 02, 2024, UBS Downgraded Applied Therapeutics Inc (NASDAQ: APLT) to Neutral. A report published by RBC Capital Mkts on November 29, 2024, Downgraded its rating to ‘Sector Perform’ for APLT. RBC Capital Mkts Initiated an Outperform rating on March 26, 2024, and assigned a price target of $12. Leerink Partners initiated its ‘Outperform’ rating for APLT, as published in its report on February 22, 2024. Barclays’s report from January 04, 2022 suggests a price prediction of $7 for APLT shares, giving the stock a ‘Equal Weight’ rating. Goldman also rated the stock as ‘Sell’.

3 Tiny Stocks Primed to Explode

The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Analysis of Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. Taking into account the quick ratio of the company, currently set at 1.06, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and APLT has an average volume of 5.56M. On a monthly basis, the volatility of the stock is set at 12.45%, whereas on a weekly basis, it is put at 12.24%, with a loss of -10.16% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.00, showing growth from the present price of $1.15, which can serve as yet another indication of whether APLT is worth investing in or should be passed over.

How Do You Analyze Applied Therapeutics Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 25.00%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 88.02% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

APLT shares are owned by institutional investors to the tune of 88.02% at present.

Related Posts